Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

835 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

NCT05882058

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extra-pulmonary Neuroendocrine Carcinoma, +9 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Mayo Clinic-Arizona Phoenix, Arizona, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 59 locations
View Trial Details
Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

NCT06131840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • IP Address: City of Hope Investigational Drug Services(IDS) Duarte, California, United States
View all 48 locations
View Trial Details
Recruiting

A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer

NCT07253142

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Fujian Cancer Hospital Fu'zhou, Fujian, China
  • Cancer Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The People's Hospital of Guangxi Zhuangzu Autonomous Region Nanning, Guangxi, China
View Trial Details
Recruiting

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

NCT05652686

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 15 locations
View Trial Details
Recruiting

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

NCT05889546

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Roudebush VA Medical Center Indianapolis, Indiana, United States
  • Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
View Trial Details
Recruiting

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

NCT07174583

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office Fort Wayne, Indiana, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 13 locations
View Trial Details

Related conditions